In May, Clinical Leader Chief Editor Ed Miseta sat down with our President and CEO Ibraheem “Ibs” Mahmood, and with Dr. Michael Snape, CEO and CSO of AMO Pharma to discuss how technology can help biotech improve the search for treatments for debilitating disorders including rare genetic disorders.
Important Cookie Information – This message will only appear once.
DrugDev websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
